The Claim
In obese women, high-dose omega-3 supplementation (4.8 g/day EPA+DHA) is associated with a transient reduction in plasma TNF-α levels during treatment, with this effect reversing after supplementation ceases, while TNF-α gene expression remains suppressed, indicating differential regulation between circulating TNF-α protein and cellular TNF-α mRNA.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
When obese women take a high dose of omega-3 fish oil supplements, their blood levels of a certain inflammation marker drop while they're taking it, but go back up after they stop. However, their cells still keep the gene for that marker turned down, which means the body is handling the marker in two different ways.
See the scientific wording
In obese women, high-dose omega-3 supplementation (4.8 g/day EPA+DHA) is associated with a transient reduction in plasma TNF-α levels during treatment, but this effect reverses after supplementation stops, while TNF-α gene expression remains suppressed, suggesting differential regulation between circulating protein and cellular mRNA.
What the research says
1 studyIn obese women, taking a high dose of omega-3 fish oil for three months lowered a key inflammation marker in the blood—but only while they were taking it. However, the genes that make that marker stayed quiet even after stopping, meaning the body’s internal instructions changed longer than the blood levels showed.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.